Gupta S, Gupta Brig M M
SDM Hospital, Jaipur.
J Assoc Physicians India. 2007 Apr;55:287-91.
Coronary artery bypass surgery (CABG) is the treatment of choice in unprotected left main coronary artery disease (ULMCA). However drug eluting stent (DES) implantations in ULMCA have ushered a revolution in the field of percutaneous coronary interventions (PCI) for left main coronary artery (LMCA) by reducing peri-procedural mortality and incidence of major adverse cardiac events (MACE). More randomized trials and follow-up studies are required before PCI with DES can be chosen as alternative to CABG.
冠状动脉搭桥术（CABG）是无保护左主干冠状动脉疾病（ULMCA）的首选治疗方法。然而，在ULMCA中植入药物洗脱支架（DES）通过降低围手术期死亡率和主要不良心脏事件（MACE）的发生率，在左主干冠状动脉（LMCA）的经皮冠状动脉介入治疗（PCI）领域引发了一场革命。在DES用于PCI可被选为CABG的替代方法之前，还需要更多的随机试验和随访研究。
Zotero 插件